Stockholders' Equity | 6. STOCKHOLDERS EQUITY Preferred stock The Company is authorized to issue up to 100,000,000 shares of preferred stock with a par value of $0.00001. At June 30, 2015 the Companys authorized 4,807,309 shares of Series A Convertible Preferred Stock with a par value of $0.0001 and $48.07309 stated value, of which were all issued and outstanding. On March 5, 2015, the Companys board of directors designated 4,807,309 shares of its preferred stock as Series A Convertible Stock (Series A) with a $48.07309 stated value, par value of $0.00001 per share. Holders of the Series A preferred stock are not entitled to receive any dividends unless specifically declared by the Companys board of directors; shall be entitled to the number of votes equal to the number of shares of common stock into which the Series A preferred stock is convertible at any regular, annual or special meeting of stockholders of the Company and will rank senior to all of the Common Stock; (ii) senior to any class or series of capital stock of the Company hereafter created specifically ranking by its terms junior to any Series A Preferred Stock ( Junior Securities Parity Securities Senior Securities On April 2, 2015, the Company issued 4,807,309 shares of its Series A Convertible Stock in exchange for 4,807,309 shares of its common stock. Common stock The Company is authorized to issue up to 500,000,000 shares of common stock with a par value of $0.00001. At June 30, 2015 and December 31, 2014, there were 39,150,805 and 38,875,805 shares issued and outstanding, respectively In February 2015, the Company entered into a Securities Purchase Agreement in which we received proceeds of $10,000 for the sale of 50,000 shares of our common stock and warrants to acquire 50,000 shares of our common stock at an exercise price of $0.24 for five years from the date of issuance. In March 2015, the Company entered into a Securities Purchase Agreement in which we received proceeds of $25,000 for the sale of 125,000 shares of our common stock and warrants to acquire 125,000 shares of our common stock at an exercise price of $0.24 for five years from the date of issuance. |